442 related articles for article (PubMed ID: 11283215)
21. Pulmonary uptake of Tc-99m-Labeled methylene diphosphonate in a patient with a parathyroid adenoma.
Herry JY; Chevet D; Moisan A; Le Pogamp P; Le Jeune JJ; Kerdiles Y
J Nucl Med; 1981 Oct; 22(10):888-90. PubMed ID: 6457136
[TBL] [Abstract][Full Text] [Related]
22. Tc-99m methylene diphosphonate uptake by numerous phleboliths in the lower extremity detected incidentally during bone scintigraphy.
Sohn MH; Jeong YJ; Lim ST; Kim DW; Jeong HJ; Yim CY
Clin Nucl Med; 2010 Apr; 35(4):289-92. PubMed ID: 20305428
[No Abstract] [Full Text] [Related]
23. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric considerations of
Brown JL; Sexton-Stallone B; Li Y; Frey EC; Treves ST; Fahey FH; Plyku D; Cao X; Choi C; Kim CH; Sgouros G; Aris JP; Bolch WE
Phys Med Biol; 2020 Dec; 65(23):235025. PubMed ID: 33263312
[TBL] [Abstract][Full Text] [Related]
25. [A case of renal uptake of Tc-99m methylene diphosphonate after radiation therapy].
Kikuchi A; Matsumoto Y; Sakurada H
Rinsho Hoshasen; 1986 Sep; 31(9):1061-4. PubMed ID: 3784045
[No Abstract] [Full Text] [Related]
26. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
27. Severe systemic reaction to (99m)Tc-methylene diphosphonate: a case report.
Balan KK; Choudhary AK; Balan A; Wishart G
J Nucl Med Technol; 2003 Jun; 31(2):76-8. PubMed ID: 12777457
[TBL] [Abstract][Full Text] [Related]
28. Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images.
Berk F; Demir H; Hacihanefioglu A; Arslan A; Erdincler O; Isgoren S; Aktolun C
Ann Nucl Med; 2002 Apr; 16(2):137-41. PubMed ID: 12043908
[TBL] [Abstract][Full Text] [Related]
29. Reduced hemithoracic uptake on 99mTc-MDP bone scintigraphy: an underrecognized sign of massive pleural effusion--a case report.
Balan KK; Ramkumar S; Faraj K; Choudhary AK
J Nucl Med Technol; 2003 Mar; 31(1):25-6. PubMed ID: 12624124
[TBL] [Abstract][Full Text] [Related]
30. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
[TBL] [Abstract][Full Text] [Related]
31. Diffuse liver and spleen accumulation on Tc-99m methylene diphosphonate bone scan.
Sun SS; Tsai SC; Su CC; Kao CH
Semin Nucl Med; 2001 Jul; 31(3):253-4. PubMed ID: 11430532
[No Abstract] [Full Text] [Related]
32. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.
Peller PJ; Ho VB; Kransdorf MJ
Radiographics; 1993 Jul; 13(4):715-34. PubMed ID: 8356264
[TBL] [Abstract][Full Text] [Related]
33. Multifactorial uptake of Tc-99m methylene diphosphonate in chronic renal failure.
Taylor RE
Clin Nucl Med; 2003 Nov; 28(11):939-40. PubMed ID: 14578718
[TBL] [Abstract][Full Text] [Related]
34. Jaw uptake of technetium-99 methylene diphosphonate in patients on biphosphonates: a word of caution.
Zanglis A; Andreopoulos D; Dima M; Baltas G; Baziotis N
Hell J Nucl Med; 2007; 10(3):177-80. PubMed ID: 18084661
[TBL] [Abstract][Full Text] [Related]
35. Abnormal uptake of Technetium-99 m hydroxymethylene diphosphonate in the liver.
Roman MR; Larcos G; Angelides S; Devadas M
Australas Radiol; 2003 Mar; 47(1):73-4. PubMed ID: 12581061
[TBL] [Abstract][Full Text] [Related]
36. Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancer.
Kawase T; Fujii H; Nakahara T; Shigematsu N; Kubo A; Kosuda S
Clin Nucl Med; 2009 Mar; 34(3):173-4. PubMed ID: 19352284
[TBL] [Abstract][Full Text] [Related]
37. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
38. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
39. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
40. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
Park-Holohan SJ; Blake GM; Fogelman I
Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
